Our top pick for
This article contains links to products or services from one or more of our advertisers or partners. We may receive a commission when you click or make a purchase using our site. Learn more about how we make money.
Tabula Rasa HealthCare, Inc is a health information services business based in the US. Tabula Rasa HealthCare shares (TRHC) are listed on the NASDAQ and all prices are listed in US Dollars. Tabula Rasa HealthCare employs 1,286 staff and has a trailing 12-month revenue of around USD$293.4 million.
|Latest market close||USD$33.9|
|52-week range||USD$30.12 - USD$69.72|
|50-day moving average||USD$36.1997|
|200-day moving average||USD$47.6174|
|Wall St. target price||USD$44.33|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-0.893|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2020-11-25)||-3.12%|
|1 month (2020-11-06)||-3.56%|
|3 months (2020-09-04)||-32.31%|
|6 months (2020-06-05)||-41.35%|
|1 year (2019-12-05)||-18.57%|
|2 years (2018-12-04)||-53.16%|
|3 years (2017-12-05)||16.90%|
|5 years (2015-12-02)||N/A|
Valuing Tabula Rasa HealthCare stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Tabula Rasa HealthCare's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Tabula Rasa HealthCare's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.2633. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Tabula Rasa HealthCare's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Tabula Rasa HealthCare's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$691,000.
The EBITDA is a measure of a Tabula Rasa HealthCare's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$293.4 million|
|Gross profit TTM||USD$103.4 million|
|Return on assets TTM||-5.82%|
|Return on equity TTM||-32.71%|
|Market capitalisation||USD$832.6 million|
TTM: trailing 12 months
There are currently 5.5 million Tabula Rasa HealthCare shares held short by investors – that's known as Tabula Rasa HealthCare's "short interest". This figure is 5.3% up from 5.2 million last month.
There are a few different ways that this level of interest in shorting Tabula Rasa HealthCare shares can be evaluated.
Tabula Rasa HealthCare's "short interest ratio" (SIR) is the quantity of Tabula Rasa HealthCare shares currently shorted divided by the average quantity of Tabula Rasa HealthCare shares traded daily (recently around 297383.04535637). Tabula Rasa HealthCare's SIR currently stands at 18.52. In other words for every 100,000 Tabula Rasa HealthCare shares traded daily on the market, roughly 18520 shares are currently held short.
However Tabula Rasa HealthCare's short interest can also be evaluated against the total number of Tabula Rasa HealthCare shares, or, against the total number of tradable Tabula Rasa HealthCare shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Tabula Rasa HealthCare's short interest could be expressed as 0.23% of the outstanding shares (for every 100,000 Tabula Rasa HealthCare shares in existence, roughly 230 shares are currently held short) or 0.2947% of the tradable shares (for every 100,000 tradable Tabula Rasa HealthCare shares, roughly 295 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Tabula Rasa HealthCare.
Find out more about how you can short Tabula Rasa HealthCare stock.
We're not expecting Tabula Rasa HealthCare to pay a dividend over the next 12 months.
Over the last 12 months, Tabula Rasa HealthCare's shares have ranged in value from as little as $30.12 up to $69.72. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tabula Rasa HealthCare's is 1.0005. This would suggest that Tabula Rasa HealthCare's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Tabula Rasa HealthCare, Inc., together with its subsidiaries, provides patient-specific and data-driven technology and solutions in the field of medication safety in the United States. The company's proprietary Medication Risk Mitigation Matrix delivers a multi-drug review, which identifies medication-related risks. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patients' medication-related information; and MedWise that provides medication decision support components for clients seeking to manage their medication risk and improve medication outcomes, and patient relationships by enhancing their existing systems. The company's cloud-based software also comprise RxCompanion, an MTM software platform designed to aid in the identification and resolution of medication and other health related problems; TruChart, an electronic health record (EHR) system for Programs of All-Inclusive Care for the Elderly (PACE) organizations; and PACElogic, which delivers real-time sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination, planning, integration with community-based providers, and various Federal and State required reporting. In addition, it offers clinical pharmacist collaboration, prescription fulfillment and reminder packaging, and pharmacy cost management services, as well as health plan management services, including risk adjustment and third party administrator services. As of December 31, 2019, the company served 237 healthcare organizations. It provides its cloud-based software solutions to prescribers, pharmacists, pharmacies, and healthcare organizations for managing the medication-related needs of patients. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.
Steps to owning and managing HTZ, with 24-hour and historical pricing before you buy.
Steps to owning and managing HELE, with 24-hour and historical pricing before you buy.
Steps to owning and managing HE, with 24-hour and historical pricing before you buy.
Steps to owning and managing GKOS, with 24-hour and historical pricing before you buy.
Steps to owning and managing EYEN, with 24-hour and historical pricing before you buy.
Steps to owning and managing EXAS, with 24-hour and historical pricing before you buy.
Steps to owning and managing EVFM, with 24-hour and historical pricing before you buy.
Steps to owning and managing MRAM, with 24-hour and historical pricing before you buy.
Steps to owning and managing EQNR, with 24-hour and historical pricing before you buy.
Steps to owning and managing SOLO, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.